Journal article
1976 and 2009 H1N1 Influenza Virus Vaccines Boost Anti-Hemagglutinin Stalk Antibodies in Humans
Abstract
BACKGROUND: Infection with pandemic H1N1 influenza A viruses (IAVs) containing hemagglutinin (HA) proteins with globular heads that differ substantially from seasonal strains results in a boost in broadly cross-reactive antibodies that bind to the HA stalk. Boosting these antibodies has become an attractive strategy for creating a universal IAV vaccine. Therefore, it was essential to determine whether vaccines containing H1N1 viruses whose head …
Authors
Miller MS; Tsibane T; Krammer F; Hai R; Rahmat S; Basler CF; Palese P
Journal
The Journal of Infectious Diseases, Vol. 207, No. 1, pp. 98–105
Publisher
Oxford University Press (OUP)
Publication Date
January 1, 2013
DOI
10.1093/infdis/jis652
ISSN
0022-1899
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AnimalsAntibodies, NeutralizingAntibodies, ViralAntibody SpecificityCase-Control StudiesCell LineCohort StudiesCross ReactionsDogsHemagglutinin Glycoproteins, Influenza VirusHumansInfluenza A Virus, H1N1 SubtypeInfluenza VaccinesInfluenza, HumanMiddle AgedPandemicsProspective StudiesRecombinant ProteinsVaccination